FOR PHYSICIANS

WE EMPOWER
ADVANCEMENTS IN
PRECISION ONCOLOGY

Taproot forms partnerships with clinics to help
them receive value for time and effort spent in
reporting patient data.

JOIN OUR NETWORK

REALITY
Collecting patient data is critical, but time-consuming. Physicians and oncologists need new revenue streams
to offset the time and costs required to collect quality data.

SOLUTION
By providing a single, comprehensive database—accessible by all industry stakeholders—we can accelerate adoption
of new tests and novel cancer therapies.

The ROOT Registry is a national observational clinical trial, enabling patients and clinicians to identify, collect, and share the highest quality cancer data. Clinics report information on behalf of patients in a format that provides the greatest research benefit. Oncologists and patients can help identify new biomarkers and treatments, and eventually find specific patients to participate in new diagnostic testing or therapeutic trials. We collect treatment response and behavioral data directly from patients through patient self-reporting—enhancing our ROOT Registry data. Taproot will continually streamline the data-collection process.

HELP BUILD A NATIONAL ONCOLOGY DATABASE THAT BENEFITS EVERYONE.

PATIENT CONSENT

Patients are asked to participate.This patient consent protects them and ensures that all data-sharing is compliant with modern privacy laws. Plus, patients can be contacted when new biomarker testing is available or when they qualify for research opportunities.

A SHARED EFFORT

Change happens when we all
work together.
When it comes to curing cancer, the power is in the
numbers. Not one oncologist or clinic can do it alone. As an oncology community, we can build something stronger and more powerful than anything we could build as individuals.

A PARTNERSHIP MODEL

Clinics are treated as partners.Partner clinics can access data for cancer research. They can also share in any net revenue from licensing that data. There’s full transparency in data sharing—so researchers always know how data is being used.

A NOVEL CLINICAL
TRIAL AND DATABASE

Incomplete or inaccurate data
benefits no one.
The right data must be collected in the right manner to be valuable. We provide tools and training for molecular classification, data entry and clinical flow—all to provide regulatory-grade data.